These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26343548)

  • 21. Toward a solid microneedle patch for rapid and enhanced local analgesic action.
    Liu Y; Zhao ZQ; Liang L; Jing LY; Wang J; Dai Y; Chen BZ; Guo XD
    Drug Deliv Transl Res; 2024 Jul; 14(7):1810-1819. PubMed ID: 38236507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication of coated polymer microneedles for transdermal drug delivery.
    Chen Y; Chen BZ; Wang QL; Jin X; Guo XD
    J Control Release; 2017 Nov; 265():14-21. PubMed ID: 28344014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
    Bachhav YG; Summer S; Heinrich A; Bragagna T; Böhler C; Kalia YN
    J Control Release; 2010 Aug; 146(1):31-6. PubMed ID: 20678988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-coated microneedles for rapid and painless local anesthesia.
    Baek SH; Shin JH; Kim YC
    Biomed Microdevices; 2017 Mar; 19(1):2. PubMed ID: 28070698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.
    Gomaa YA; Garland MJ; McInnes FJ; Donnelly RF; El-Khordagui LK; Wilson CG
    Eur J Pharm Biopharm; 2014 Feb; 86(2):145-55. PubMed ID: 23461860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides.
    Dillon C; Hughes H; O'Reilly NJ; McLoughlin P
    Int J Pharm; 2017 Jun; 526(1-2):125-136. PubMed ID: 28461268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
    Jeong HR; Kim JY; Kim SN; Park JH
    Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin.
    Kochhar JS; Quek TC; Soon WJ; Choi J; Zou S; Kang L
    J Pharm Sci; 2013 Nov; 102(11):4100-8. PubMed ID: 24027112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle-Assisted Percutaneous Transport of Magnesium Sulfate.
    Ghimirey KB; Ita K
    Curr Drug Deliv; 2020; 17(2):140-147. PubMed ID: 31845631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tearable dissolving microneedle system for shortening application time.
    Lee WJ; Han MR; Kim JS; Park JH
    Expert Opin Drug Deliv; 2019 Mar; 16(3):199-206. PubMed ID: 30773938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization.
    Yao G; Quan G; Lin S; Peng T; Wang Q; Ran H; Chen H; Zhang Q; Wang L; Pan X; Wu C
    Int J Pharm; 2017 Dec; 534(1-2):378-386. PubMed ID: 29051119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine.
    Nayak A; Das DB
    Biotechnol Lett; 2013 Sep; 35(9):1351-63. PubMed ID: 23690030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
    Singh ND; Banga AK
    J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microneedle-assisted transdermal delivery of Zolmitriptan: effect of microneedle geometry, in vitro permeation experiments, scaling analyses and numerical simulations.
    Uppuluri CT; Devineni J; Han T; Nayak A; Nair KJ; Whiteside BR; Das DB; Nalluri BN
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1292-1303. PubMed ID: 28375038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.
    Milewski M; Stinchcomb AL
    Pharm Res; 2011 Jan; 28(1):124-34. PubMed ID: 20577787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.
    Sadeqi A; Kiaee G; Zeng W; Rezaei Nejad H; Sonkusale S
    Sci Rep; 2022 Feb; 12(1):1853. PubMed ID: 35115643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.
    Puri A; Nguyen HX; Banga AK
    Int J Cosmet Sci; 2016 Oct; 38(5):512-23. PubMed ID: 27009797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.